2. By isolating differentiated cell or tissue for
short term nonregenerative cultures
Isolating precursor cells
Stem cell culture
3. FASTIDIOUS
Neurite outgrowth is encouraged by a polypeptide
nerve growth factor
Neurons used are hippocampal, cortical, spinal,
cerebellar etc
Disadv : long term culture diffficult
4. COATED PLATES- POLY L LYSINE OR
COLLAGEN
NGF
GLIAL FACTORS
PROTOCOL CONTRIBUTED BY BERNT
ENGELSEN AND ROLF BJERKVIG
7. Dissect cerebella aseptically and place in
HBSS
Mince to 0.5 cubic mm
Wash with HBSS three times
Trypsinisation
Add growth medium: stop the action of
trypsin
Trituration to obtain single cell suspension
8. Centrifuge at 200g for 5 min..
Resuspend the pellet in growth
medium and seed the cells at a conc
of 2.5- 3×106 cells/plate
After 2-4 days incubate the culture
with 5-10μM cytosine arabinoside for
24 hrs
Change to regular culture medium
9. Neuron specific enolase antibody
Tetanus toxin marker
Glial fibrillar acidic protein for astrocyte
contamination
10. 3 TYPES
› ASTOCYTES
› MICROGLIAL
› OLIGODENDROCYTES
Human adult normal astroglial lines from brain
lines express glial fibrillary acidic protein
12. PROTOCOL- OLFACTORY ENSHEATHING
CELLS CULTURE
Collect olfactory lobes
Mince well
Collaginase treatment for 30-45 min at 37°C
Centifuge 100g 5 min
Resuspend pellet in Ca and Mg free HBSS
Centrifuge and culture 5×106 cells/ml of
DMEM
13. Labelling with galactocerebroside to distinguish betweeen OEC
and oligodendrocytes
Done prior to cell plating
Primary antibody O4 and secondary antibody anti-GalC
14.
15. Isolate cerebrum
Peel off the meninges and transfer cortex to a tube containing cold dissection buffer placed on
ice
Pour tissue into a dish and wash with modified DMEM/F12 culture medium with 10%
FBS, 1% glutamine, and gentamicin
Mechanically disintegration
Trypsinization and DNase treatment- Incubate at 37ºC for 25 minutes.swirl tube every 5
minutes
Wash tissue with Glial Medium twice
Dilute suspended cells in 10 mL of Glial Medium, and pass the solution through a 40 uM
strainer
Centrifuge cells at 1700 rpm for 5 minute
Resuspend pellet with 10 mL Glial Medium
Seed 2 x106 cells/T75 in 15 ml Glial medium
Incubate the flasks at 37oC in 5% CO2 for 2-3 days without disruption.
Change the medium in each flask every 2-3 days by aspirating and adding 15 mL fresh Glial
Medium until confluency is achieved (after approximately 6-7 days)
16. Once the primary cultures are confluent, change the medium
and tighten flask caps. Wrap flasks in plastic and place on
shaker platform horizontally with medium covering the cells
Shake at 350 rpm for 6 hours at 37°C to separate
oligodendrocytes from astrocytes
Change medium (10mL) and replace flasks on shaker for 18
more hours
Remove flasks from shaker, and aseptically pour contents into
a new T75. Incubate
Change medium in flasks (10mL), tighten caps, cover in
plastic, and shake, again, for 24 more hours (change medium
in 6 hr)
Aseptically pour contents into a new T75 and incubate until
confluent
Reseed at 3 x 105 cells in each T75 flask
fresh culture must be prepared every three weeks
17. Passage
Sterilize petri dishes by coating with 1 mg/ml of
PureCol Collagen, washing with sterile ddH20, and
allowing to dry in culture hood for 30 minutes
The next day. wash glial cells with PBS once
Add 3-5 mL of trypsin to the culture flask; incubate at
37°C for 5 minutes
Add 5-7 mL of Glial Medium to the culture flask, and
then transfer cells to a 50 mL tube
Centrifuge cells at 1700 rpm for 5 minutes
Remove the supernatant and resuspend the cells in 10
mL of Glial Medium
Seed cells at 7.5 X1O4 cells/6cm dish in 6mL Glial
Medium.
20. to study the membrane properties of
Schwann cells
axon-Schwann cell communication
how these alter in neuropathic conditions
to use Schwann cells for the repair of
lesioned peripheral nerve
to exploit their potential for regeneration in
CNS lesions.
21.
22. o USE AS A MODEL
Advantages
Neuronal activity in controlled env
Observation possible at several points and methods
Disadvantages
Inter Connectivity is lost
Lacks body
PATHOLOGICAL STUDIES
CELL BASED THERAPIES
› Glial cell used in spinal cord injuries